(Big News on ACTC – Editorial explaining it in plain language below. )
Press Release Source: Advanced Cell Technology, Inc.
Advanced Cell Technology Reports Visual Function Rescue in Animals Utilizing Human Embryonic Stem Cell-Derived Retinal Cells Thursday September 21, 7:00 am ET
Transplanted Cells Shown Capable of Rescuing Photoreceptor Cells in RCS Rats with Retinal Disease
WORCESTER, Mass.--(BUSINESS WIRE)--Sept. 21, 2006--Advanced Cell Technology, Inc. (OTCBB: ACTC.OB - News) today announced that company scientists and their collaborators rescued visual function in rats through implantation of retinal pigment epithelial cells (RPE) derived from human embryonic stem (hES) cells. The study results were reported in a paper entitled "Human Embryonic Stem Cell-Derived Cells Rescue Visual Function in Dystrophic RCS Rats" published online today ahead of print in the Fall 2006 issue of the journal Cloning and Stem Cells.
LOSS OF VISUAL FUNCTION SAVED IN RATS BY STEM CELLS
September 21, 2006 Dr. John Faessel, Editor SmallcapInsights.com jfaessel@smallcapinsights.com
In another dramatic display of stem cells’ potential for healing, (ACTC)’s scientists and their collaborators report* the prevention of certain loss of visual function in rats with the use of human embryonic stem cell-derived retinal cells. The results further validate the astonishing advances made in the field of stem cell research.
Caused by a genetic trait, these rats had lost their photoreceptor cells over a period of several months following birth. The condition is similar to that occurring in human macular degeneration. Photo receptor cells are responsible for converting light into nerve signals that can ultimately be transmitted to the brain via the optic nerve.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.